Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on Olmesartan Medoxomil in Patients with Moderate to Severe Hypertension Not Controlled on Amlodipine
2005-000450-75Phase 3Completed
- Sponsor
- Daiichi Sankyo
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of olmesartan in essential hypertension (3 arms), sponsored by Daiichi Sankyo. Primary endpoint: Change in sitting trough diastolic blood pressure at Week 16. Started Jun 2005; status: completed.
02
Drugs
olmesartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2005-000450-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000450-75.